Open-Label, Multicenter, Phase 4 Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease
Condition(s):Dry EyeLast Updated:March 13, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Dry EyeLast Updated:March 13, 2024Recruiting
Condition(s):MyopiaLast Updated:March 12, 2024Not yet recruiting
Condition(s):Refractive AmetropiaLast Updated:October 25, 2023Completed
Condition(s):AstigmatismLast Updated:October 6, 2023Completed
Condition(s):Refractive AmetropiaLast Updated:January 5, 2024Completed
Condition(s):AstigmatismLast Updated:August 31, 2023Recruiting
Condition(s):Allergic ConjunctivitisLast Updated:September 1, 2023Completed
Condition(s):AstigmatismLast Updated:February 22, 2023Completed
Condition(s):Dry Eye Disease (DED)Last Updated:March 12, 2024Completed
Condition(s):Myopia and Hyperopia and PresbyopiaLast Updated:September 1, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.